Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science.
Our values underpin our company culture. They describe the professional behaviors we expect from our employees.
Learn more about treatments currently offered by Novartis Innovative Medicines, Sandoz and Advanced Accelerator Applications.
Innovative Medicines, made up of two separate commercial organizations, Innovative Medicines International and Innovative Medicines US, commercializes innovative patented medicines to enhance health outcomes.
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
Global Drug Development (GDD)
GDD oversees the development of new medicines and manages Novartis clinical trials to bring innovative medicines to patients.
Novartis Institutes for Biomedical Research (NIBR)
NIBR collaborates across scientific and organizational boundaries, focusing on powerful new technologies to help produce therapeutic breakthroughs.
Operations includes Manufacturing and Supply, and Services and Technology Solutions, providing high-quality products, services and technology solutions.